Dynavax Technologies | Ativo Circulante



Current Assets Alterar Data
AbbVie USD 25.58B 2.2B 2024-12
Adma Biologics USD 331.41M 13.22M 2024-12
Amgen USD 29.03B 2.26B 2024-12
AstraZeneca USD 25.83B 1.67B 2024-12
Biogen USD 7.46B 626.3M 2024-12
BioMarin Pharmaceutical USD 3.23B 175.84M 2024-12
Bristol-Myers Squibb USD 29.78B 1.7B 2024-12
Dynavax Technologies USD 848.94M 77.3M 2024-12
Gilead Sciences USD 19.17B 4.39B 2024-12
Glaxosmithkline GBP 17B 301M 2024-12
Merck USD 38.78B 1.58B 2024-12
Neurocrine Biosciences USD 1.72B 151.9M 2024-12
Novartis USD 29.7B 1.56B 2024-12
Pfizer USD 50.36B 7.14B 2024-12
Regeneron Pharmaceuticals USD 27.21B 7.88B 2024-12
Roche Holding CHF 40.04B 6.41B 2024-12
Sarepta Therapeutics USD 3.07B 388.09M 2024-12
TG Therapeutics USD 566.36M 7.71M 2024-12
Vertex Pharmaceuticals USD 9.6B 207.7M 2024-12



Dynavax Technologies Ativo Circulante - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Mar 2025.